Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CERILLION PLC Board/Management Information 2024

Jul 1, 2024

7556_mang_2024-07-01_baffecf2-0c58-4a05-a67d-61cb901b98cd.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4414U

Cerillion PLC

01 July 2024

AIM: CER

Cerillion plc

("Cerillion" or "the Company")

Nominated Adviser and Joint Broker

Cerillion, the billing, charging and customer relationship management software solutions provider, announces that, following the completion of the all-share merger between Liberum Capital Limited and Panmure Gordon Group Limited , the Company has changed its Nominated Adviser and Joint Broker to Panmure Liberum Limited with immediate effect.

Enquiries:

Cerillion plc c/o KTZ Communications
Louis Hall, CEO T: 020 3178 6378
Andrew Dickson, CFO
Panmure Liberum Limited (Nomad and Joint Broker) T: 020 3100 2000
Bidhi Bhoma, Edward Mansfield, Matthew Hogg
Singer Capital Markets (Joint Broker) T: 020 7496 3000
Rick Thompson, James Fischer
KTZ Communications T: 020 3178 6378
Katie Tzouliadis, Robert Morton

About Cerillion

www.cerillion.com

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management, with a 23-year track record in providing comprehensive revenue and customer management solutions. The Company has around 80 customers across 45 countries, principally serving the telecommunications market.

The Company is headquartered in London and also has operations in India (in Pune, Ahmedabad, and Indore), Bulgaria (in Sofia), Singapore, USA (in Boston) and Australia (in Sydney).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APPFPMATMTATBJI